Understanding the National Drug Code (NDC)
The National Drug Code (NDC) is a unique 11-digit number assigned to each drug product, formatted as 5-4-2 digits. For the NDC 24979-0112, this code identifies a specific drug product, which in this case is the Potassium Chloride Extended-Release Tablets.
Drug Description
Potassium Chloride Extended-Release Tablets, identified by the NDC 24979-0112, are used for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis. These tablets are manufactured by TWi Pharmaceuticals, Inc.[4].
Market Analysis
Current Pricing
To analyze the market and project prices for this drug, we need to look at current pricing trends. However, specific pricing data for NDC 24979-0112 is not readily available in the provided sources. Generally, prices for prescription drugs can fluctuate based on various factors such as production costs, market demand, and regulatory changes.
Pricing Trends in Prescription Drugs
The pharmaceutical market is subject to significant price fluctuations. For instance, the Oregon Drug Price Transparency Program reported that the median price increase for generic drugs was 19.9% in 2022, while brand name drugs saw a median increase of 13.4%[2].
Impact of Regulatory Oversight
Regulatory oversight can significantly impact drug pricing. Programs like Oregon's Drug Price Transparency Program require manufacturers to report price increases and new high-cost drugs, which can lead to greater transparency and potentially influence pricing decisions[2].
Price Projections
General Trends
Given the broader trends in the pharmaceutical industry, here are some general projections:
-
Inflation Rates: Vizient projects an overall drug price inflation rate of 3.81% for 2025, which could influence the pricing of all drugs, including potassium chloride extended-release tablets[3].
-
Supply Chain Factors: The price of a prescription drug is influenced by interactions and financial negotiations within the pharmaceutical supply chain. Factors such as rebates, discounts, and fees can affect the final cost to consumers[2].
Specific Projections for Potassium Chloride Extended-Release Tablets
Without specific historical pricing data for NDC 24979-0112, it is challenging to make precise price projections. However, here are some considerations:
-
Generic Drug Pricing: Since potassium chloride extended-release tablets are likely to be generic, they might follow the median price increase trend for generic drugs, which was 19.9% in 2022[2].
-
Market Demand: If the demand for potassium chloride extended-release tablets remains stable or increases due to clinical needs, prices might rise accordingly.
-
Regulatory Environment: Any changes in regulatory requirements or transparency programs could impact pricing. For example, if states implement upper payment limits or other cost-control measures, it could cap price increases[2].
Key Takeaways
- NDC Identification: The NDC 24979-0112 identifies potassium chloride extended-release tablets.
- Current Use: These tablets are used for treating and preventing hypokalemia.
- Pricing Trends: Generic drugs, including potassium chloride tablets, may see price increases similar to the median increase of 19.9% observed in 2022.
- Regulatory Impact: Regulatory oversight and transparency programs can influence pricing decisions.
- Inflation Projections: Overall drug price inflation rates, such as the projected 3.81% for 2025, can affect the pricing of these tablets.
FAQs
What is the NDC code used for?
The NDC code is a unique 11-digit number that identifies a specific drug product, including its manufacturer, product, and packaging.
What is the purpose of potassium chloride extended-release tablets?
These tablets are used for the treatment and prophylaxis of hypokalemia with or without metabolic alkalosis.
How do regulatory programs impact drug pricing?
Regulatory programs, such as Oregon's Drug Price Transparency Program, require manufacturers to report price increases and can lead to greater transparency and potential caps on price increases.
What is the projected drug price inflation rate for 2025?
Vizient projects an overall drug price inflation rate of 3.81% for 2025.
Can generic drugs see significant price increases?
Yes, generic drugs can see significant price increases. For example, the median price increase for generic drugs in 2022 was 19.9%.
Sources
- NC Medicaid: NDC Special Bulletin - NC Medicaid.
- Oregon Drug Price Transparency Program: Prescription Drug Price Transparency Results and Recommendations.
- Vizient, Inc.: Vizient projects drug price inflation at 3.81%.
- DailyMed: Potassium chloride tablet, extended release.
Last updated: 2025-01-02
